Company Information
USD
2.4
- (-2%)
NASDAQ:GCTK, GLUCOTRACK INC
End of Day: 14 June 2024 GMT-4
GlucoTrack Inc is a medical device company. It focuses on the design, development, and commercialization of non-invasive glucose monitoring devices for use by people with diabetes and pre-diabetics. The company has developed a non-invasive glucose monitor, the GlucoTrack model DF-F glucose monitoring device, which is designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain, inconvenience, and difficulty of conventional spot finger stick devices. It also focuses on developing a wireless module for transmission of measurement data captured by the GlucoTrack model DF-F to a cloud-based server.
Address
301 Route 17 North
Suite 800
Rutherford
Website
Classification
Key Executives
Mr. James S. Cardwell
CFO
Mr. Paul V. Goode, PhD
CEO/President
Ms. Erin Catherine Carter
Director
Mr. Luis Malave
Director
Dr. Robert Fischell
Director
Mr. Shimon Rapps
Director
Mr. James P. Thrower
Vice President, Divisional
Mr. Allen E. Danzig
Director
Mr. Andrew Sycoff
Director
Ownership
Institution Holdings
Sabby Management LLC
428,908 (1.752%)
ALERUS FINANCIAL NA
69,279 (0.283%)
Citadel Advisors Llc
32,717 (0.134%)
Boston Financial Mangement Inc
26,372 (0.108%)
Accurate Wealth Management, LLC
22,098 (0.090%)
Virtu Financial LLC
18,913 (0.077%)
TWO SIGMA SECURITIES, LLC
13,322 (0.054%)
UBS Group AG
4,800 (0.020%)
Individual Holdings
Mr. Allen E. Danzig
15,048 (0.097%)
Make Smart Investment Choices